Masaru Sasaki

This study shows that Prostaglandin E2 reverses myofibroblast differentiation in EoE via the cAMP/YAP/THBS-1 pathway, suggesting it as a potential treatment for fibrostenotic EoE.

This study identifies FOXM1 as a key driver of epithelial disruption in EoE, showing that its inhibition restores differentiation, reduces hyperplasia, and improves barrier function.

This paper introduces an unsupervised alignment method using Gromov-Wasserstein optimal transport for neuroscience, showing its ability to reveal structural distinctions in representations across different data domains.